Nature, ISSN 0028-0836, 12/2011, Volume 480, Issue 7377, pp. 336 - 343
Variable regions 1 and 2 (V1/V2) of human immunodeficiency virus-1 (HIV-1) gp120 envelope glycoprotein are critical for viral evasion of antibody...
SYSTEM | POTENT NEUTRALIZATION | DEXTRAN SULFATE | EPITOPE | MULTIDISCIPLINARY SCIENCES | IMMUNODEFICIENCY-VIRUS TYPE-1 | ENVELOPE GLYCOPROTEIN | RECEPTOR | BINDING | T-CELLS | SOFTWARE | AIDS Vaccines - immunology | Glycopeptides - chemistry | Molecular Sequence Data | Antibody Affinity - immunology | Crystallography, X-Ray | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | Glycopeptides - immunology | Antibody Specificity - immunology | HIV Antibodies - immunology | HIV-1 - chemistry | Protein Structure, Quaternary | Conserved Sequence | Polysaccharides - chemistry | HIV Envelope Protein gp120 - chemistry | Protein Structure, Tertiary | Amino Acid Sequence | Binding Sites, Antibody - immunology | Models, Molecular | Glycosylation | Polysaccharides - immunology | HIV Antibodies - chemistry | AIDS Vaccines - chemistry | Amino Acid Motifs | HIV-1 - immunology | Immune Evasion | Hydrogen Bonding | Antigen-Antibody Complex - chemistry | Antibodies, Neutralizing - chemistry | Epitopes - chemistry | Antigen-Antibody Complex - immunology | Viral envelopes | Genetic aspects | Research | HIV (Viruses) | Structure | Binding sites (Biochemistry) | Proteins | Crystals | Vaccines | ANTIBODIES | AIDS VIRUS | BASIC BIOLOGICAL SCIENCES | AFFINITY | BIOLOGY | GLYCOPROTEINS | VULNERABILITY | ANTIGENS | IMMUNOLOGY | 60 APPLIED LIFE SCIENCES
SYSTEM | POTENT NEUTRALIZATION | DEXTRAN SULFATE | EPITOPE | MULTIDISCIPLINARY SCIENCES | IMMUNODEFICIENCY-VIRUS TYPE-1 | ENVELOPE GLYCOPROTEIN | RECEPTOR | BINDING | T-CELLS | SOFTWARE | AIDS Vaccines - immunology | Glycopeptides - chemistry | Molecular Sequence Data | Antibody Affinity - immunology | Crystallography, X-Ray | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | Glycopeptides - immunology | Antibody Specificity - immunology | HIV Antibodies - immunology | HIV-1 - chemistry | Protein Structure, Quaternary | Conserved Sequence | Polysaccharides - chemistry | HIV Envelope Protein gp120 - chemistry | Protein Structure, Tertiary | Amino Acid Sequence | Binding Sites, Antibody - immunology | Models, Molecular | Glycosylation | Polysaccharides - immunology | HIV Antibodies - chemistry | AIDS Vaccines - chemistry | Amino Acid Motifs | HIV-1 - immunology | Immune Evasion | Hydrogen Bonding | Antigen-Antibody Complex - chemistry | Antibodies, Neutralizing - chemistry | Epitopes - chemistry | Antigen-Antibody Complex - immunology | Viral envelopes | Genetic aspects | Research | HIV (Viruses) | Structure | Binding sites (Biochemistry) | Proteins | Crystals | Vaccines | ANTIBODIES | AIDS VIRUS | BASIC BIOLOGICAL SCIENCES | AFFINITY | BIOLOGY | GLYCOPROTEINS | VULNERABILITY | ANTIGENS | IMMUNOLOGY | 60 APPLIED LIFE SCIENCES
Journal Article
Nature, ISSN 0028-0836, 09/2008, Volume 455, Issue 7209, pp. 109 - 113
The envelope glycoproteins (Env) of human and simian immunodeficiency viruses (HIV and SIV, respectively) mediate virus binding to the cell surface receptor...
LACKING | REPLICATION | EPITOPE | VACCINE DESIGN | MULTIDISCIPLINARY SCIENCES | ENVELOPE GLYCOPROTEIN | RECEPTOR | HUMAN-IMMUNODEFICIENCY-VIRUS | NEUTRALIZATION | BINDING | ELECTRON TOMOGRAPHY | Models, Molecular | HIV Envelope Protein gp120 - metabolism | Protein Subunits - metabolism | Cryoelectron Microscopy | HIV Envelope Protein gp120 - immunology | CD4 Antigens - chemistry | HIV-1 - chemistry | Immunoglobulin Fab Fragments - chemistry | Protein Structure, Quaternary | Protein Binding | Protein Subunits - chemistry | HIV Envelope Protein gp120 - chemistry | Immunoglobulin Fab Fragments - immunology | CD4 Antigens - metabolism | Usage | CD4 lymphocytes | Tomography | Glycoproteins | Genetic aspects | Research | HIV (Viruses) | Changes | Software packages | Maps | Molecular structure | Human immunodeficiency virus--HIV | Electron microscopes | Data collection | Viruses
LACKING | REPLICATION | EPITOPE | VACCINE DESIGN | MULTIDISCIPLINARY SCIENCES | ENVELOPE GLYCOPROTEIN | RECEPTOR | HUMAN-IMMUNODEFICIENCY-VIRUS | NEUTRALIZATION | BINDING | ELECTRON TOMOGRAPHY | Models, Molecular | HIV Envelope Protein gp120 - metabolism | Protein Subunits - metabolism | Cryoelectron Microscopy | HIV Envelope Protein gp120 - immunology | CD4 Antigens - chemistry | HIV-1 - chemistry | Immunoglobulin Fab Fragments - chemistry | Protein Structure, Quaternary | Protein Binding | Protein Subunits - chemistry | HIV Envelope Protein gp120 - chemistry | Immunoglobulin Fab Fragments - immunology | CD4 Antigens - metabolism | Usage | CD4 lymphocytes | Tomography | Glycoproteins | Genetic aspects | Research | HIV (Viruses) | Changes | Software packages | Maps | Molecular structure | Human immunodeficiency virus--HIV | Electron microscopes | Data collection | Viruses
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 2011, Volume 415, Issue 4, pp. 680 - 685
► SAXS data analysis and modeling provided global shape of CD4–IgG2 and its complexes with HIV-1 gp120. ► Models of ternary complex revealed that first two...
CD4–IgG2 | Structure reconstruction | Engineered antibody | Small angle X-ray scattering | HIV-1 gp120 | CD4-IgG2 | BIOLOGICAL MACROMOLECULES | SMALL-ANGLE SCATTERING | SOLUBLE CD4 | VIRIONS | BIOCHEMISTRY & MOLECULAR BIOLOGY | PRO 542 | HUMAN-IMMUNODEFICIENCY-VIRUS | BIOPHYSICS | DISSOCIATION | TYPE-1 | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Models, Chemical | X-Ray Diffraction | Antibodies, Neutralizing - chemistry | Humans | Immunoglobulin Fab Fragments - chemistry | Scattering, Small Angle | Immunoglobulin Fab Fragments - immunology | CD4 Immunoadhesins - immunology | CD4 Immunoadhesins - chemistry | Models | HIV (Viruses) | Analysis | Immunoglobulin G
CD4–IgG2 | Structure reconstruction | Engineered antibody | Small angle X-ray scattering | HIV-1 gp120 | CD4-IgG2 | BIOLOGICAL MACROMOLECULES | SMALL-ANGLE SCATTERING | SOLUBLE CD4 | VIRIONS | BIOCHEMISTRY & MOLECULAR BIOLOGY | PRO 542 | HUMAN-IMMUNODEFICIENCY-VIRUS | BIOPHYSICS | DISSOCIATION | TYPE-1 | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Models, Chemical | X-Ray Diffraction | Antibodies, Neutralizing - chemistry | Humans | Immunoglobulin Fab Fragments - chemistry | Scattering, Small Angle | Immunoglobulin Fab Fragments - immunology | CD4 Immunoadhesins - immunology | CD4 Immunoadhesins - chemistry | Models | HIV (Viruses) | Analysis | Immunoglobulin G
Journal Article
Science, ISSN 0036-8075, 11/2005, Volume 310, Issue 5750, pp. 1025 - 1028
The third variable region (V3) of the HIV-1 gp120 envelope glycoprotein is immunodominant and contains features essential for coreceptor binding. We determined...
Receptors | HIV | Antibodies | Atoms | Research facilities | Viruses | Reports | Trimers | Cell membranes | Binding sites | HIV 1 | V3 LOOP | SOLUBLE CD4 | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | ENVELOPE GLYCOPROTEIN | RECEPTOR | ANTIBODY | HUMAN-IMMUNODEFICIENCY-VIRUS | TYPE-1 | BINDING | NEUTRALIZATION | Humans | Molecular Sequence Data | Crystallography, X-Ray | HIV Envelope Protein gp120 - metabolism | HIV Envelope Protein gp120 - immunology | Receptors, CCR5 - metabolism | HIV Antibodies - immunology | HIV-1 - chemistry | Peptide Fragments - immunology | HIV Envelope Protein gp120 - chemistry | Binding Sites | Protein Structure, Tertiary | Amino Acid Sequence | HIV-1 - metabolism | Peptide Fragments - metabolism | Crystallization | Models, Molecular | Receptors, CXCR4 - metabolism | HIV-1 - immunology | Peptide Fragments - chemistry | Hydrogen Bonding | CD4 Antigens - chemistry | Protein Binding | Receptors, CCR5 - chemistry | Protein Conformation | Receptors, CXCR4 - chemistry | Immunodominant Epitopes | CD4 Antigens - metabolism | HIV (Viruses) | Analysis | Research | Glycoproteins | Immunology | Molecular structure | Human immunodeficiency virus--HIV
Receptors | HIV | Antibodies | Atoms | Research facilities | Viruses | Reports | Trimers | Cell membranes | Binding sites | HIV 1 | V3 LOOP | SOLUBLE CD4 | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | ENVELOPE GLYCOPROTEIN | RECEPTOR | ANTIBODY | HUMAN-IMMUNODEFICIENCY-VIRUS | TYPE-1 | BINDING | NEUTRALIZATION | Humans | Molecular Sequence Data | Crystallography, X-Ray | HIV Envelope Protein gp120 - metabolism | HIV Envelope Protein gp120 - immunology | Receptors, CCR5 - metabolism | HIV Antibodies - immunology | HIV-1 - chemistry | Peptide Fragments - immunology | HIV Envelope Protein gp120 - chemistry | Binding Sites | Protein Structure, Tertiary | Amino Acid Sequence | HIV-1 - metabolism | Peptide Fragments - metabolism | Crystallization | Models, Molecular | Receptors, CXCR4 - metabolism | HIV-1 - immunology | Peptide Fragments - chemistry | Hydrogen Bonding | CD4 Antigens - chemistry | Protein Binding | Receptors, CCR5 - chemistry | Protein Conformation | Receptors, CXCR4 - chemistry | Immunodominant Epitopes | CD4 Antigens - metabolism | HIV (Viruses) | Analysis | Research | Glycoproteins | Immunology | Molecular structure | Human immunodeficiency virus--HIV
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 09/2013, Volume 135, Issue 35, pp. 13113 - 13120
Critical to the search for an effective HIV-1 vaccine is the development of immunogens capable of inducing broadly neutralizing antibodies (BnAbs). A key first...
HIV-1 | BETA-MANNOPYRANOSIDES | NEUTRALIZING ANTIBODY PG9 | IMMUNODEFICIENCY-VIRUS TYPE-1 | HIGH-MANNOSE | CONVERGENT | GLYCOPROTEINS | LINKED GLYCOPEPTIDE | GLYCAN RECOGNITION | SULFOXIDE METHOD | CHEMISTRY, MULTIDISCIPLINARY | AIDS Vaccines - immunology | Glycopeptides - chemistry | Models, Molecular | Molecular Sequence Data | Crystallography, X-Ray | Antigens - chemistry | AIDS Vaccines - chemistry | HIV Envelope Protein gp120 - immunology | Glycopeptides - immunology | HIV-1 - immunology | Antigens - immunology | HIV Envelope Protein gp120 - chemistry | Carbohydrate Conformation | Care and treatment | Helix-loop-helix motif | Analysis | Protein biosynthesis | Diagnosis | Research | HIV (Viruses) | Protein-protein interactions
HIV-1 | BETA-MANNOPYRANOSIDES | NEUTRALIZING ANTIBODY PG9 | IMMUNODEFICIENCY-VIRUS TYPE-1 | HIGH-MANNOSE | CONVERGENT | GLYCOPROTEINS | LINKED GLYCOPEPTIDE | GLYCAN RECOGNITION | SULFOXIDE METHOD | CHEMISTRY, MULTIDISCIPLINARY | AIDS Vaccines - immunology | Glycopeptides - chemistry | Models, Molecular | Molecular Sequence Data | Crystallography, X-Ray | Antigens - chemistry | AIDS Vaccines - chemistry | HIV Envelope Protein gp120 - immunology | Glycopeptides - immunology | HIV-1 - immunology | Antigens - immunology | HIV Envelope Protein gp120 - chemistry | Carbohydrate Conformation | Care and treatment | Helix-loop-helix motif | Analysis | Protein biosynthesis | Diagnosis | Research | HIV (Viruses) | Protein-protein interactions
Journal Article
Annual Review of Immunology, ISSN 0732-0582, 2006, Volume 24, Issue 1, pp. 739 - 769
The glycoprotein (gp) 120 subunit is an important part of the envelope spikes that decorate the surface of HIV-1 and a major target for neutralizing...
Antigen engineering | AIDS | Vaccine design | Neutralizing antibodies | INTERMOLECULAR DISULFIDE BOND | V3 LOOP | CORECEPTOR-BINDING-SITE | CD4 RECEPTOR-BINDING | neutralizing antibodies | IMMUNOLOGY | antigen engineering | HUMAN-IMMUNODEFICIENCY-VIRUS | PROTECTIVE EFFICACY | N-LINKED GLYCOSYLATION | vaccine design | TYPE-1 ENVELOPE GLYCOPROTEIN | HUMAN MONOCLONAL-ANTIBODIES | HIV Envelope Protein gp120 - genetics | HIV Infections - prevention & control | HIV Infections - virology | Humans | Membrane Glycoproteins - chemistry | AIDS Vaccines - immunology | Models, Molecular | Neutralization Tests | Epitopes - genetics | HIV-1 - genetics | HIV Envelope Protein gp120 - immunology | HIV Infections - immunology | HIV-1 - immunology | Models, Immunological | Animals | HIV Antibodies - immunology | Viral Envelope Proteins - chemistry | Protein Engineering | Receptors, HIV - immunology | Viral Envelope Proteins - immunology | Epitopes - chemistry | HIV Envelope Protein gp120 - chemistry | Membrane Glycoproteins - immunology | Simian Immunodeficiency Virus - immunology
Antigen engineering | AIDS | Vaccine design | Neutralizing antibodies | INTERMOLECULAR DISULFIDE BOND | V3 LOOP | CORECEPTOR-BINDING-SITE | CD4 RECEPTOR-BINDING | neutralizing antibodies | IMMUNOLOGY | antigen engineering | HUMAN-IMMUNODEFICIENCY-VIRUS | PROTECTIVE EFFICACY | N-LINKED GLYCOSYLATION | vaccine design | TYPE-1 ENVELOPE GLYCOPROTEIN | HUMAN MONOCLONAL-ANTIBODIES | HIV Envelope Protein gp120 - genetics | HIV Infections - prevention & control | HIV Infections - virology | Humans | Membrane Glycoproteins - chemistry | AIDS Vaccines - immunology | Models, Molecular | Neutralization Tests | Epitopes - genetics | HIV-1 - genetics | HIV Envelope Protein gp120 - immunology | HIV Infections - immunology | HIV-1 - immunology | Models, Immunological | Animals | HIV Antibodies - immunology | Viral Envelope Proteins - chemistry | Protein Engineering | Receptors, HIV - immunology | Viral Envelope Proteins - immunology | Epitopes - chemistry | HIV Envelope Protein gp120 - chemistry | Membrane Glycoproteins - immunology | Simian Immunodeficiency Virus - immunology
Journal Article
Virology, ISSN 0042-6822, 2005, Volume 339, Issue 2, pp. 213 - 225
We have identified two -phenyl- ′-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamide analogs as a novel class of human immunodeficiency virus type 1 (HIV-1) entry...
Inhibition | CD4–gp120 interaction | Cell–cell fusion | HIV-1 entry | Virus–cell fusion | Cell-cell fusion | Virus-cell fusion | CD4-gp120 interaction | Anti-HIV Agents - pharmacology | Binding, Competitive | Virus Replication - drug effects | CD4 Antigens - drug effects | Humans | Oxamic Acid - analogs & derivatives | HIV Envelope Protein gp120 - metabolism | Oxamic Acid - pharmacology | Anti-HIV Agents - chemistry | Receptors, HIV - antagonists & inhibitors | HIV-1 - physiology | CD4 Antigens - chemistry | HIV-1 - chemistry | Protein Binding - drug effects | Oxamic Acid - chemistry | Anti-HIV Agents - isolation & purification | CD4 Antigens - metabolism | Protein Structure, Tertiary - drug effects | Prevention | Reverse transcriptase | Proteases | Analysis | Chemical properties | Lead compounds | HIV (Viruses) | Health aspects | Organic compounds
Inhibition | CD4–gp120 interaction | Cell–cell fusion | HIV-1 entry | Virus–cell fusion | Cell-cell fusion | Virus-cell fusion | CD4-gp120 interaction | Anti-HIV Agents - pharmacology | Binding, Competitive | Virus Replication - drug effects | CD4 Antigens - drug effects | Humans | Oxamic Acid - analogs & derivatives | HIV Envelope Protein gp120 - metabolism | Oxamic Acid - pharmacology | Anti-HIV Agents - chemistry | Receptors, HIV - antagonists & inhibitors | HIV-1 - physiology | CD4 Antigens - chemistry | HIV-1 - chemistry | Protein Binding - drug effects | Oxamic Acid - chemistry | Anti-HIV Agents - isolation & purification | CD4 Antigens - metabolism | Protein Structure, Tertiary - drug effects | Prevention | Reverse transcriptase | Proteases | Analysis | Chemical properties | Lead compounds | HIV (Viruses) | Health aspects | Organic compounds
Journal Article
Angewandte Chemie International Edition, ISSN 1433-7851, 04/2013, Volume 52, Issue 16, pp. 4435 - 4439
Chain of command: Multi‐block glycopolymers made of mannose (M, see figure), glucose, and di(ethylene glycol) ethyl ether (D) monomers were synthesized using a...
block copolymers | polymerization | glycosylation | polymers | supramolecular chemistry | LIGAND-BINDING | RECOGNITION | CLICK CHEMISTRY | SET-LRP | CHEMISTRY, MULTIDISCIPLINARY | LECTIN | LIVING RADICAL POLYMERIZATION | DC-SIGN | GLYCOPROTEIN | HIV ENTRY | Polymers - chemical synthesis | Polymers - pharmacology | HIV Envelope Protein gp120 - antagonists & inhibitors | Polymerization | Dendritic Cells - drug effects | Polymers - chemistry | Molecular Structure | HIV Envelope Protein gp120 - chemistry | Dendritic Cells - virology | Binding Sites - drug effects | Medical colleges | Equipment and supplies | Fire extinction | Block copolymers | Proteins | Binding | HIV | Glycopolymers | Mannose | Glucose | Ethers | Monomers
block copolymers | polymerization | glycosylation | polymers | supramolecular chemistry | LIGAND-BINDING | RECOGNITION | CLICK CHEMISTRY | SET-LRP | CHEMISTRY, MULTIDISCIPLINARY | LECTIN | LIVING RADICAL POLYMERIZATION | DC-SIGN | GLYCOPROTEIN | HIV ENTRY | Polymers - chemical synthesis | Polymers - pharmacology | HIV Envelope Protein gp120 - antagonists & inhibitors | Polymerization | Dendritic Cells - drug effects | Polymers - chemistry | Molecular Structure | HIV Envelope Protein gp120 - chemistry | Dendritic Cells - virology | Binding Sites - drug effects | Medical colleges | Equipment and supplies | Fire extinction | Block copolymers | Proteins | Binding | HIV | Glycopolymers | Mannose | Glucose | Ethers | Monomers
Journal Article
Nature, ISSN 0028-0836, 02/2007, Volume 445, Issue 7129, pp. 732 - 737
The remarkable diversity, glycosylation and conformational flexibility of the human immunodeficiency virus type 1 (HIV-1) envelope (Env), including substantial...
DOMAIN | PROTEIN | RECOGNITION | MULTIDISCIPLINARY SCIENCES | GP41 | IMMUNODEFICIENCY-VIRUS TYPE-1 | HUMAN MONOCLONAL-ANTIBODY | ENVELOPE GLYCOPROTEIN | BINDING SITES | RECEPTOR | ANTIGEN | Molecular Weight | HIV-1 - drug effects | Models, Molecular | Neutralization Tests | HIV Envelope Protein gp120 - metabolism | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | HIV-1 - immunology | HIV-1 - physiology | HIV Antibodies - immunology | CD4 Antigens - chemistry | HIV-1 - chemistry | Conserved Sequence | Protein Conformation | Epitopes - chemistry | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - pharmacology | Binding Sites | CD4 Antigens - metabolism | Proteins | Human immunodeficiency virus | HIV | Molecular structure | Binding sites
DOMAIN | PROTEIN | RECOGNITION | MULTIDISCIPLINARY SCIENCES | GP41 | IMMUNODEFICIENCY-VIRUS TYPE-1 | HUMAN MONOCLONAL-ANTIBODY | ENVELOPE GLYCOPROTEIN | BINDING SITES | RECEPTOR | ANTIGEN | Molecular Weight | HIV-1 - drug effects | Models, Molecular | Neutralization Tests | HIV Envelope Protein gp120 - metabolism | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | HIV-1 - immunology | HIV-1 - physiology | HIV Antibodies - immunology | CD4 Antigens - chemistry | HIV-1 - chemistry | Conserved Sequence | Protein Conformation | Epitopes - chemistry | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - pharmacology | Binding Sites | CD4 Antigens - metabolism | Proteins | Human immunodeficiency virus | HIV | Molecular structure | Binding sites
Journal Article
10.
Full Text
Sensitive electrochemical detection of gp120 based on the combination of NBD-556 and gp120
Talanta, ISSN 0039-9140, 05/2019, Volume 196, pp. 486 - 492
As is known, the employment of molecular imprinting polymer (MIP) as specific sensing materials in sensors, namely MIP-based sensors. In this contribution, we...
NBD-556 | Gp120 | CNF-Bi composites | Electrochemical sensor | Molecularly imprinted polymer | CHEMISTRY, ANALYTICAL | MOLECULARLY IMPRINTED POLYMERS | GLASSY-CARBON ELECTRODE | CHITOSAN | ENVELOPE GLYCOPROTEIN | GRAPHENE NANOPLATELETS | RECEPTOR | SENSOR | HIV GP120 | PROTEIN CONFORMATION | BINDING
NBD-556 | Gp120 | CNF-Bi composites | Electrochemical sensor | Molecularly imprinted polymer | CHEMISTRY, ANALYTICAL | MOLECULARLY IMPRINTED POLYMERS | GLASSY-CARBON ELECTRODE | CHITOSAN | ENVELOPE GLYCOPROTEIN | GRAPHENE NANOPLATELETS | RECEPTOR | SENSOR | HIV GP120 | PROTEIN CONFORMATION | BINDING
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 07/2011, Volume 208, Issue 7, pp. 1419 - 1433
The HIV-1 envelope trimer adopts a quaternary conformation that effectively shields neutralization-sensitive domains and thus represents a major obstacle for...
MEDICINE, RESEARCH & EXPERIMENTAL | TYPE-1 ISOLATE | CHRONIC INFECTION | INTEGRIN ALPHABETA | SOLUBLE CD4 | HUMORAL IMMUNITY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | RECEPTOR-BINDING | SUBTYPE-B | DISEASE PROGRESSION | GLYCOSYLATION SITES | HIV Envelope Protein gp120 - genetics | HIV Antibodies | Humans | Molecular Sequence Data | HIV Envelope Protein gp120 - metabolism | HIV Envelope Protein gp120 - immunology | HIV-1 - chemistry | Base Sequence | Peptide Fragments - immunology | Protein Structure, Quaternary | Protein Interaction Domains and Motifs | HIV Envelope Protein gp120 - chemistry | Peptide Fragments - genetics | Antibodies, Neutralizing | Amino Acid Sequence | Cell Line | Peptide Fragments - metabolism | Models, Molecular | HIV-1 - genetics | Cross Reactions | HIV-1 - immunology | Models, Immunological | Peptide Fragments - chemistry | Epitopes - chemistry | DNA, Viral - genetics
MEDICINE, RESEARCH & EXPERIMENTAL | TYPE-1 ISOLATE | CHRONIC INFECTION | INTEGRIN ALPHABETA | SOLUBLE CD4 | HUMORAL IMMUNITY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | RECEPTOR-BINDING | SUBTYPE-B | DISEASE PROGRESSION | GLYCOSYLATION SITES | HIV Envelope Protein gp120 - genetics | HIV Antibodies | Humans | Molecular Sequence Data | HIV Envelope Protein gp120 - metabolism | HIV Envelope Protein gp120 - immunology | HIV-1 - chemistry | Base Sequence | Peptide Fragments - immunology | Protein Structure, Quaternary | Protein Interaction Domains and Motifs | HIV Envelope Protein gp120 - chemistry | Peptide Fragments - genetics | Antibodies, Neutralizing | Amino Acid Sequence | Cell Line | Peptide Fragments - metabolism | Models, Molecular | HIV-1 - genetics | Cross Reactions | HIV-1 - immunology | Models, Immunological | Peptide Fragments - chemistry | Epitopes - chemistry | DNA, Viral - genetics
Journal Article